DOI: 10.1001/jamaoto.2026.2132 ISSN: 2168-6181

Subcutaneous Pembrolizumab and the Coordination of Neoadjuvant Immunotherapy in Head and Neck Cancer

Lauren E. Miller, James W. Rocco
Show PDF Cite

This Viewpoint considers the implications of an expanded surgical role in deliver care for head and neck squamous cell carcinoma.

More from our Archive